Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer (Q57581296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Birgitte Vrou Offersen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Rikke Riisbro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Nils Brünner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jens Overgaard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Danish Breast Cancer Cooperative Group (DBCG) Tumor Biology Committee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

782-791

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

The urokinase-type plasminogen activator system in cancer metastasis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

The Myofibroblast Is the Predominant Plasminogen Activator Inhibitor-1-Expressing Cell Type in Human Breast Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

The role of the fibrinolytic system in corneal angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860601116383

10.1080/02841860601116383

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17653901%20AND%20SRC:MED&resulttype=core&format=json